A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2016
At a glance
- Drugs PF 4457845 (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Pfizer
- 13 Nov 2015 Status changed from suspended to discontinued, as reported by ClinicalTrials.gov.
- 19 Jun 2015 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 04 May 2015 Status changed from suspended to active, no longer recruiting as per ClinicalTrials.gov record.